U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 074137
Company: HOSPIRA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BUPRENORPHINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE EQ 0.3MG BASE/ML INJECTABLE;INJECTION Prescription AP No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
06/03/1996 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
07/21/2005 SUPPL-8 Labeling

Label is not available on this site.

02/05/2003 SUPPL-5 Labeling

Label is not available on this site.

02/14/2001 SUPPL-3 Manufacturing (CMC)-Microbiology-Processing

Label is not available on this site.

12/02/1996 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

12/02/1996 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

BUPRENORPHINE HYDROCHLORIDE

INJECTABLE;INJECTION; EQ 0.3MG BASE/ML
TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BUPRENEX BUPRENORPHINE HYDROCHLORIDE EQ 0.3MG BASE/ML INJECTABLE;INJECTION Prescription Yes AP 018401 INDIVIOR INC
BUPRENORPHINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE EQ 0.3MG BASE/ML INJECTABLE;INJECTION Prescription No AP 078331 AM REGENT
BUPRENORPHINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE EQ 0.3MG BASE/ML INJECTABLE;INJECTION Prescription No AP 076931 HIKMA
BUPRENORPHINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE EQ 0.3MG BASE/ML INJECTABLE;INJECTION Prescription No AP 074137 HOSPIRA
BUPRENORPHINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE EQ 0.3MG BASE/ML INJECTABLE;INJECTION Prescription No AP 206586 PAR STERILE PRODUCTS
Back to Top